Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-21
1996-08-06
Killos, Paul J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A01N 4342
Patent
active
055434177
ABSTRACT:
Described is a combination method using selective inhibitors of 5.alpha.-reductase 1 and/or 2 including 7.beta.-substituted 4-aza-5.alpha.-cholestan-3-ones and related 4-aza-5.alpha.-androstan-3-one compounds which are useful in the treatment of acne vulgaris in combination with at least one agent selected from an antibacterial, keratolytic, and/or an anti-inflammatory.
REFERENCES:
patent: 2227876 (1941-01-01), Bolt
patent: 3239417 (1966-03-01), Ditullio et al.
patent: 3264301 (1966-08-01), Doorenbos et al.
patent: 3285918 (1966-11-01), Doorenbos et al.
patent: 4220775 (1980-09-01), Rasmusson et al.
patent: 4377584 (1983-03-01), Rasmusson et al.
patent: 4732897 (1988-03-01), Cainelli et al.
patent: 4760071 (1988-07-01), Rasmusson et al.
patent: 4845104 (1989-07-01), Carlin et al.
patent: 4859681 (1989-08-01), Rasmusson et al.
patent: 5120840 (1992-06-01), Weintraub et al.
patent: 5130424 (1992-07-01), Weintraub
patent: 5143909 (1992-09-01), Weintraub et al.
patent: 5155107 (1992-10-01), Panzeri et al.
patent: 5215894 (1993-06-01), Arison
"Synthesis and Antimicrobial Properties of 17.beta.-Isopentyloxy-4-aza-5.alpha.-androstane and the 4-Methyl Derivative", Norman J. Doorenbos and William E. Solomons, Journal of Pharmaceutical Sciences, vol., 62, No. 4, 1973, pp. 638-640.
"4,17 .alpha.-Dimethyl-4-aza-5.alpha.-androstan-17.beta.-ol Acetate and Related Azasteroids", Norman J. Doorenbos and Sister Jane Marie Brown, Journal of Pharmaceutical Sciences, vol. 60, No. 8, 1971, pp. 1234-1235.
"Synthesis and Evaluation of Antimicrobial Properties of Amidinoazaandrostanes and Guanidinoazaandrostanes", Norman J. Doorenbos and Jack C. Kim, Journal of Pharmaceutical Sciences, vol. 63, No. 4, 1974, pp. 620-622.
"Azasteroids as Inhibitors of Rat Prostatic 5.alpha.-Reductase", Gary H. Rasmusson, et al., Journal of Medicinal Chemistry, vol. 27, 1984, pp. 1690-1701.
"Azasteroids: Structure-Activity Relationships for Inhibition of 5.alpha.-Reductase and of Androgen Receptor Binding", Gary H. Rasmusson, et al., Journal of Medicinal Chemistry, vol. 29, 1986, pp. 2298-2315.
"Kinetic Parameters of 5.alpha.-Reductase Activity in Stroma and Epithelium of Normal, Hyperplastic, and Carcinomatous Human Prostates", Nicholas Bruchovsky, et al., Journal of Clincal Endocrinology and Metabolism, vol. 67, No. 4, 1988, pp. 806-816.
"Comparison of Nuclear 5.alpha.-Reductase Activities in the Stromal and Epithelial Fractions of Human Prostatic Tissue", Robert W. Hudson, Journal of Steroid Biochemistry, vol. 26, No. 3, 1987, pp. 349-353.
"Steroid 5.alpha.-Reductase in Cultured Human Fibroblasts-Biochemical and Genetic Evidence for Two Distinct Enzyme Activities", Ronald J. Moore and Jean D. Wilson, The Journal of Biological Chemistry, vol. 254, No. 19, 1976, pp. 5895-5900.
"Expression Cloning and Regulation of Steroid 5.alpha.-Reductase, an Enzyme Essential for Male Sexual Differentiation", Stefan Andersson, et al., The Journal of Biological Chemistry, vol. 264, No. 27, 1989, pp. 16249-16255.
"Structural and biochemical properties of cloned and expressed human and rat steroid 5.alpha.-reductases", Stefan Andersson, et al., Proceedings of the National Academy of Sciences, USA, vol. 87, 1990, pp. 3640-3644.
"Deletion of steroid 5 .alpha.-reductase 2 gene in male pseudohermaphroditism", Stefan Andersson, et al., Nature, vol. 354, 1991, pp. 159-161.
"Syndromes of Androgen Resistance", Jean D. Wilson, Biology of Reproduction, vol. 46, 1992, pp. 168-173.
"Indentification and selective inhibition of an isozyme of steroid 5.alpha.-reductase in human scalp", Georgianna Harris, et al., Proceedngs of the National Academy of Sciences, USA, vol. 89, 1992, pp. 10787-10791.
Fitch Catherine D.
Killos Paul J.
Merck & Co. , Inc.
North Robert J.
Winokur Melvin
LandOfFree
Combination method of treating acne using 4-AZA-5.alpha.-cholest does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination method of treating acne using 4-AZA-5.alpha.-cholest, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination method of treating acne using 4-AZA-5.alpha.-cholest will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2191262